Curated News:

Medical Meetings

Add to Favorites Subscribe Share
fbshare-Medical Meetings

Showing results

6170 of 3636
2019-A-1048-AATS.jpg
  • Embargo expired:
    6-May-2019 8:05 AM EDT

Article ID: 712255

New Model Improves Staging and Risk Predictions for Esophageal Cancer Patients

American Association for Thoracic Surgery (AATS)

A new nomogram for assessing metastatic risk in esophageal cancer patients shows promise for more accurate risk-stratification, which is particularly relevant for stage T2 patients.

Released:
2-May-2019 7:05 AM EDT
2019-05-04-DrMoisheLiberman_CreditCHUM.JPG
  • Embargo expired:
    4-May-2019 12:00 PM EDT

Article ID: 712306

Lung cancer: less invasive surgery for faster recovery

Universite de Montreal

In a large international clinical study presented at the 99th Annual Meeting of the American Association for Thoracic Surgery, Dr. Moishe Liberman and his team showed that thoracoscopic lobectomy—video-assisted thoracoscopic surgery (VATS)—combined with pulmonary artery sealing using an ultrasonic energy device reduced the risk of post-operative bleeding, complications and pain.

Released:
2-May-2019 2:05 PM EDT
AATS_HORZ-LOGO-TAG_RGB.jpg
  • Embargo expired:
    4-May-2019 11:05 AM EDT

Article ID: 711904

A New Technique for Minimally Invasive Surgery in Lung Cancer – Ultrasonic Device is Safe and Effective for Lung Vessel Sealing in Minimally Invasive Lobectomy

American Association for Thoracic Surgery (AATS)

According to a new study, an ultrasonic vessel-sealing device can improve patient outcomes by reducing the incidence of thoracotomy conversion for VATS/robotic anatomical lung resection

Released:
25-Apr-2019 9:55 AM EDT
MenPCPhoto.jpg
  • Embargo expired:
    4-May-2019 10:30 AM EDT

Article ID: 712335

Similar Incidence of DNA Damage Response Pathway Alterations between Localized and Metastatic Prostate Cancer

Rutgers Cancer Institute of New Jersey

Investigators at Rutgers Cancer Institute of New Jersey have found that approximately 30 percent of men with localized prostate cancer may have alterations in DNA damage response pathways.

Released:
3-May-2019 7:05 AM EDT
UHealth_horizontal_png_red.png

Article ID: 712360

Induced Labor Not More Expensive to Health Care System than Spontaneous Labor

University of Utah Health

The results of a joint study between University of Utah Health and Intermountain Healthcare show inducing labor one week early costs the same as waiting for spontaneous labor.

Released:
3-May-2019 12:05 PM EDT
mmc-logo.gif

Article ID: 712333

Study shows drug reduces risk of relapse with neuromyelitis optica

Mayo Clinic

The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder (NMOSD). Mayo Clinic researchers and international collaborators published their findings in the New England Journal of Medicine.

Released:
3-May-2019 12:05 AM EDT
aan-logo.gif
  • Embargo expired:
    2-May-2019 4:00 PM EDT

Article ID: 712056

Blood Pressure Drug Shows No Benefit in Parkinson’s Disease

American Academy of Neurology (AAN)

A study of a blood pressure drug does not show any benefit for people with Parkinson’s disease, according to findings released today that will be presented at the American Academy of Neurology’s 71st Annual Meeting in Philadelphia, May 4 to 10, 2019. The drug isradipine had shown promise in small, early studies and hopes were high that this could be the first drug to slow the progression of the disease.

Released:
29-Apr-2019 1:00 PM EDT
Signature-Vertical.png

Article ID: 712278

Aging baby boomers push sky high incidence of shingles of the eye

Michigan Medicine - University of Michigan

More Americans are being diagnosed with eye complications of shingles, but older adults can call the shots on whether they develop the painful rash that can cost them their eyesight.

Released:
2-May-2019 12:00 PM EDT
AATS_HORZ-LOGO-TAG_RGB.jpg

Article ID: 712253

AATS 99th Annual Meeting Tip Sheet

American Association for Thoracic Surgery (AATS)

The American Association for Thoracic Surgery 99th Annual Meeting takes place at the Metro Toronto Convention Center, Toronto, Canada, May 4 - 7, 2019.

Released:
2-May-2019 9:00 AM EDT
aan-logo.gif
  • Embargo expired:
    1-May-2019 4:00 PM EDT

Article ID: 712055

Experimental Drug Shows Promise for Genetic Form of ALS

American Academy of Neurology (AAN)

An early stage trial of an investigational therapy for amyotrophic lateral sclerosis (ALS) suggests that people could tolerate the experimental drug and, in exploratory results, the experimental drug was linked to possible slower progression in people with a genetic form of the disease caused by mutations in a gene called superoxide dismutase 1 (SOD1). The preliminary study released today will be presented at the American Academy of Neurology’s 71st Annual Meeting in Philadelphia, May 4 to 10, 2019.

Released:
29-Apr-2019 1:00 PM EDT

Showing results

6170 of 3636

Chat now!